Oncolytics Biotech® Reports Second Quarter 2022 Financial Results and Recent Operational Highlights
August 11, 2022
Oncocyte Announces Market Entry and Early Adopter Program for Transplant Rejection Monitoring Business
July 13, 2022
Related Post
-
-
Acasti Pharma Reports First Quarter 2023 Operational Results
August 11, 2022
-
Helbiz to Offer On-Demand Taxi Services to Widen International Intermodal Offering
August 11, 2022
-
Pressure BioSciences Announces Approval to Manufacture Hemp-Derived CBD Products in Massachusetts, Including Their Revolutionary CBD Nanoemulsions
August 11, 2022